User contributions for EProba

11:5211:52, 30 September 2024 diff hist +12 Tan et al. (2018): Bromelain has significant clinical benefits after extraction of the third molar during chemotherapy in patients with hematologic tumor No edit summary
11:3211:32, 30 September 2024 diff hist −1 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
11:2611:26, 30 September 2024 diff hist −35 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
11:2311:23, 30 September 2024 diff hist +59 Stauder et al. (1991): Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary
11:1811:18, 30 September 2024 diff hist −894 Publication: Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzyme No edit summary current
11:1111:11, 30 September 2024 diff hist +7 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
11:1011:10, 30 September 2024 diff hist +20 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
11:0811:08, 30 September 2024 diff hist +166 Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial No edit summary
10:3810:38, 30 September 2024 diff hist +24 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
10:2810:28, 30 September 2024 diff hist +96 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
10:1410:14, 30 September 2024 diff hist +2,955 Publication: Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary current
09:3209:32, 30 September 2024 diff hist 0 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
09:2709:27, 30 September 2024 diff hist −9 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
09:0609:06, 30 September 2024 diff hist +517 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary

20:1120:11, 29 September 2024 diff hist +570 Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects No edit summary
19:4919:49, 29 September 2024 diff hist +15 Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy No edit summary
19:4219:42, 29 September 2024 diff hist +33 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary
19:3819:38, 29 September 2024 diff hist +8 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary
19:3619:36, 29 September 2024 diff hist −6 Publication: Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary current
19:3419:34, 29 September 2024 diff hist +11 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary

17:4417:44, 27 September 2024 diff hist +803 Marucci et al. (2017): Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer No edit summary
17:0717:07, 27 September 2024 diff hist +3,997 Marucci et al. (2017): Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer No edit summary
15:4215:42, 27 September 2024 diff hist +4,248 N Marucci et al. (2017): Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer Created page with "{{Reference |Reference=Publication: ouble-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer }} {{Study Note |Study Note=Most patients who receive radiotherapy to the head and neck suffer from inflammation of the oral mucosa during the course of radiotherapy. In this study, the researchers investigated the effect of a commercial herbal mouthwash made..."
15:2815:28, 27 September 2024 diff hist +1,615 N Publication: Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer Created page with "{{Publication |Title=Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer |Topic=Aloe vera |Author=Marucci, L; Farneti, A; Di Ridolfi, P; Pinnaro, P; Pellini, R; Giannarelli, D; Vici, P; Conte, M; Landoni, V; Sanguineti, G |Year=2017 |Journal=Head & Neck |DOI=https://doi.org/10.1002/hed.24832 |Authors Abstract=Background: There is no widely accep..." current

15:2315:23, 16 September 2024 diff hist +1,435 Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy No edit summary

14:4314:43, 30 August 2024 diff hist +5,228 N Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy Created page with "{{Reference |Reference=Publication: Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy }} {{Study Note}} =Brief summary= In this study, the researchers tested the use of a skin cream containing aloe vera extract on the severity of radiation-induced skin reactions. Women with breast cancer were randomised into one of three arms. Arm 1 used either baby powder or corn starch on the skin..."
13:5113:51, 30 August 2024 diff hist +2,214 N Publication: Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy Created page with "{{Publication |Title=Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy |Topic=Aloe vera |Author=Hoopfer, D; Holloway, C; Gabos, Z; Alidrisi, M; Chafe, S; Krause, B; Lees, A; Mehta, N; Tankel, K; Strickland, F; Hanson, J; King, C; Ghosh, S; Severin, D |Year=2015 |Journal=Clinical Breast Cancer |DOI=https://doi.org/10.1016/j.clbc.2014.12.006 |Authors Abstract=It has been proposed that..." current
13:4013:40, 30 August 2024 diff hist +1,632 Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue No edit summary
09:4609:46, 30 August 2024 diff hist +731 Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue No edit summary
09:2809:28, 30 August 2024 diff hist +5,376 Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue No edit summary

15:3215:32, 29 August 2024 diff hist +257 Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue No edit summary
15:1315:13, 29 August 2024 diff hist −16 Williams et al. (1996): Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity No edit summary
15:1115:11, 29 August 2024 diff hist +3,578 N Williams et al. (1996): Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity Created page with "{{Reference |Reference=Publication: Williams (1996) Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity }} {{Study Note}} =Brief summary= In this study, researchers investigated the effect of an aloe vera gel (98%) on radiation-induced dermatitis. Women with breast carcinoma who underwent radiotherapy applied either the aloe gel or a placebo gel to the irradiated skin. Both the patients and their treating doct..."
15:0115:01, 29 August 2024 diff hist +1,297 N Publication: Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity Created page with "{{Publication |Title=Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity |Topic=Aloe vera |Author=Williams, MS; Burk, M; Loprinzi, CL; Hill, M; Schomberg, PJ; Nearhood, K; O'Fallon, JR; Laurie, JA; Shanahan, TG; Moore, RL; Urias, RE; Kuske, RR; Engel, RE; Eggleston, WD |Year=1996 |Journal=International Journal of Radiation Oncology, Biology, Physics |DOI=https://doi.org/10.1016/s0360-3016(96)00320-3 |Authors A..." current
14:4714:47, 29 August 2024 diff hist +90 Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy No edit summary
11:4111:41, 29 August 2024 diff hist +3,470 N Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy Created page with "{{Reference |Reference=Publication: The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy }} {{Study Note}} =Brief summary= In this study, researchers investigated the effect of an aloe vera gel (100%) on skin reactions in patients undergoing radiotherapy. During radiotherapy, patients were given a mild, unscented soap with which to cleanse their skin. About half of the patients also received th..."
11:3811:38, 29 August 2024 diff hist +1,929 N Publication: The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy Created page with "{{Publication |Title=The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy |Topic=Aloe vera |Author=Olsen, DL; Raub, W Jr; Bradley, C; Johnson, M; Macias, JL; Love, V; Markoe, A |Year=2001 |Journal=Oncology Nursing Forum |DOI=https://pubmed.ncbi.nlm.nih.gov/11338761/ |Authors Abstract=Purpose/objectives: To determine whether the use of mild soap and aloe vera gel versus mild soap alone would dec..." current

17:0717:07, 26 August 2024 diff hist +636 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary

12:5212:52, 21 August 2024 diff hist +1,807 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
11:3511:35, 21 August 2024 diff hist +2,463 Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer No edit summary
10:5710:57, 21 August 2024 diff hist +8,657 N Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= This study includes 88 patients with breast cancer. At the start of the study, the patients had already undergone surgery and had their lymph nodes in the breast/armpit area removed. In particular, these patients all suffer from unilateral lymphoedema, which developed after the operation. The patients in this study all receive ‘CDT therapy’, consisting of manual lymph drainage, bandaging of the..."
09:4409:44, 21 August 2024 diff hist +709 N Publication: Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer Created page with "{{Publication |Title=Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer |Topic=Enzymes (bromelain papain) |Author=Kasseroller, R; Wenning, HG |Year=2003 |Journal=The European Journal of Lymphology and related problem |DOI=- |Authors Abstract=Aim of the study was to investigate the influence of a proteolytic enzyme, the drug Wobenzym, (Mucos Emulsionsges. mbH, Wien. Austria), on the..."

14:0714:07, 15 August 2024 diff hist +2,818 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary
13:5213:52, 15 August 2024 diff hist +1,376 Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente No edit summary
11:1311:13, 15 August 2024 diff hist +5,576 N Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente Created page with "{{Reference |Reference=Publication: Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente }} {{Study Note}} =Brief summary= A total of 51 patients with various forms of lung cancer were included in this study. All patients included received the same radiotherapy. However, one arm with 25 patients also received enzyme therapy using klysms. The question of this study is whether this enzyme therapy can positively influence the tolerability of..."
10:3910:39, 15 August 2024 diff hist +251 N Publication: Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente Created page with "{{Publication |Title=Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente |Topic=Enzymes (bromelain papain) |Author=Wrbka, E; Kodras, B |Year=1978 |Journal=Wiener Medizinische Wochenschrift |DOI=? |Authors Abstract=? }}"

14:5114:51, 14 August 2024 diff hist +3,378 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary
13:1713:17, 14 August 2024 diff hist +2,274 Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers No edit summary

30 September 2024

29 September 2024

27 September 2024

16 September 2024

30 August 2024

29 August 2024

26 August 2024

21 August 2024

20 August 2024

15 August 2024

14 August 2024